Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-23
2009-11-17
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
07618991
ABSTRACT:
The invention concerns compounds of formula (I):Wherein X, Y, R1, R2, R3and R4are as described herein. The invention also concerns a method for preparing same and the therapeutic use thereof.
REFERENCES:
patent: 5145860 (1992-09-01), Takasugi et al.
patent: 5229386 (1993-07-01), Takasugi et al.
patent: 5254576 (1993-10-01), Romine et al.
patent: 5348969 (1994-09-01), Romine et al.
patent: 5380854 (1995-01-01), Romine et al.
patent: 0576357 (1993-12-01), None
patent: WO 03/078413 (2003-09-01), None
patent: WO 2004/058255 (2004-07-01), None
patent: WO 2005/073197 (2005-08-01), None
patent: WO 2005/080357 (2005-09-01), None
[Patani, George A. Bioisosterism: A rational approach in drug design. Chem. Rev. 96 (1996) 3147-3176.]
[Tanaka, Akito. Antiplatelet Agents Based on Cyclooxygenase Inhibition without Ulcerogenesis Evaluation and Synthesis of 4,5-Bis(4-methoxyphenyl)-2-substituted-thiazoles. J. Med. Chem. 37 (1994) 1189-1199.]
[Pyl, Theodor. Bicyclic heterocyclic compounds with a common nitrogen atom. IX. Imidazo [5, 1-b] thiazoles. Justus Liebigs Annalen der Chemie. 676 (1964) 144-150.]
[Pyl, Theodor. Bicyclic heterocyclic compounds with a common nitrogen atom. VII. Preparation of 7-benzoylaminopyrrolo [2, 1-b] thiazoles. Justus Liebigs Annalen der Chemie. 676 (1964) 141-150.]
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Lange, J. H. M., et. al., Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1 Cannabinoid Receptor Antagonists, J. Med. Chem. (2005), vol. 48, ppo. 1823-1838.
Plummer, C. W., et. al., Synthesis and Activity of 4,5-Diarylimidazoles as Human CB1 Receptor Inverse Agonists, Bioorganic & Medicinal Chemistry Letters, vol. 15, (2005), pp. 1441-1446.
Barth Francis
Rinaldi-Carmona Murielle
Gupta Balaram
Saeed Kamal A
Sanofi-Aventis
Shterengarts Samantha L
LandOfFree
Heterocyclic derivatives, preparation and therapeutic use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic derivatives, preparation and therapeutic use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives, preparation and therapeutic use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4085664